Future Tech: Almost Here, Round-the-corner Future Technology Podcast

Dale R. Pfost, PhD, Director and Cofounder, Microbiome Therapeutics, delivers an interesting overview of microbiome therapeutics, prediabetes treatment, and more. Dr. Pfost has more than 25 years of solid leadership experience in the biotechnology industry. He has held many important executive positions at numerous respected companies, and was the Chief Executive of six biotechnology companies, most recently as the founding CEO of MicroBiome Therapeutics. Dr. Pfost earned a BS degree from the University of California, Santa Barbara and his PhD in physics from Brown University. Dr. Pfost explains the premise of his company, Microbiome Therapeutics. As he states, the field of the microbiome encompasses a wide range of human health issues. With the increase in popularity of probiotic foods, clearly there is a strong interest in improving gut health through diet. Dr. Pfost states that through his 30 years of experience in the biotechnology field, the microbiome arena is one of the richest and broadest paradigm